Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations

<b>Background/Objectives:</b> Cancer and bacterial cases are increasing. Hence, new drugs to treat these diseases are paramount. Ferrocene-based hybrid compounds were synthesizedas potential cancer and bacteria therapeutics. <b>Methods:</b> The synthesized compounds were char...

Full description

Saved in:
Bibliographic Details
Main Authors: Sijongesonke Peter, Eric Morifi, Mutshinyalo Nwamadi, Samson Olaitan Oselusi, Asongwe Lioniel Tantoh, Thierry Youmbi Fonkui, Derek Tantoh Ndinteh, Blessing Atim Aderibigbe
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceutics
Subjects:
hybrids
ferrocene
drug resistance
pharmacokinetics
anticancer
antibacterial
Online Access:https://www.mdpi.com/1999-4923/17/6/722
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items